Abstract
A number of mechanisms modify thyroid hormone (TH) signaling at the cellular level. To restore TH signaling in patients with hypothyroidism or in patients with the syndrome of TH resistance, it is necessary to quantify the action of THs in a tissue-specific manner. The development of biomarkers that are tissue-specific and respond to TH is a significant first step toward understanding and possibly modifying TH signaling in health and disease states.
Get full access to this article
View all access options for this article.
References
1.
Bianco
AC
,
Dumitrescu
A
,
Gereben
B
,
Ribeiro
MO
,
Fonseca
TL
,
Fernandes
GW
,
Bocco
B
. 2019 . Paradigms of dynamic control of thyroid hormone signaling . Endocr Rev , 40 :1000 –1047 .
2.
Jonklaas
J
,
Bianco
AC
,
Bauer
AJ
,
Burman
KD
,
Cappola
AR
,
Celi
FS
,
Cooper
DS
,
Kim
BW
,
Peeters
RP
,
Rosenthal
MS
,
Sawka
AM
. 2014 . Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement . Thyroid , 24 :1670 –1751 .
3.
Peterson
SJ
,
McAninch
EA
,
Bianco
AC
. 2016 . Is a normal TSH synonymous with “euthyroidism” in levothyroxine monotherapy? . J Clin Endocrinol Metab , 101 :4964 –4973 .
4.
Dumitrescu
AM
,
Refetoff
S
. 2013 . The syndromes of reduced sensitivity to thyroid hormone . Biochim Biophys Acta , 1830 :3987 –4003 .
5.
Knock
S
,
Johann
K
,
Harder
L
,
Wirth
E
,
Renko
K
,
Höfig
C
,
Kracke
V
,
Hackler
J
,
Rauner
M
,
Köhrle
J
,
Homuth
G
,
Brabant
G
,
Mittag
J
. 2020 . CD5L constitutes a novel biomarker for integrated hepatic thyroid hormone action . Thyroid , 30 :908 –923 .
6.
Werneck de Castro
JP
,
Fonseca
TL
,
Ueta
CB
,
McAninch
EA
,
Abdalla
S
,
Wittmann
G
,
Lechan
RM
,
Gereben
B
,
Bianco
AC
. 2015 . Differences in hypothalamic type 2 deiodinase ubiquitination explain localized sensitivity to thyroxine . J Clin Invest , 125 :769 –781 .
7.
Mateo
RCI
,
Hennessey
JV
. 2019 . Thyroxine and treatment of hypothyroidism: seven decades of experience . Endocrine , 66 :10 –17 .
8.
Means
JH
,
DeGroot
LJ
,
Stanbury
JB
. 1963 . Adult Hypothyroid States: The Thyroid and Its Diseases . McGraw-Hill Book Co. , New York , pp. 287 –353 .
9.
Mandel
SJ
,
Brent
GA
,
Larsen
PR
. 1993 . Levothyroxine therapy in patients with thyroid disease . Ann Intern Med , 119 :492 –502 .
10.
Gereben
B
,
McAninch
EA
,
Ribeiro
MO
,
Bianco
AC
. 2015 . Scope and limitations of iodothyronine deiodinases in hypothyroidism . Nat Rev Endocrinol , 11 :642 –652 .
11.
Ridgway
EC
,
Cooper
DS
,
Walker
H
,
Daniels
GH
,
Chin
WW
,
Myers
G
,
Maloof
F
. 1980 . Therapy of primary hypothyroidism with L-triiodothyronine: discordant cardiac and pituitary responses . Clin Endocrinol , 13 :479 –488 .
12.
Stock
JM
,
Surks
MI
,
Oppenheimer
JH
. 1974 . Replacement dosage of L-thyroxine in hypothyroidism. A re-evaluation . N Engl J Med , 290 :529 –533 .
13.
Bianco
AC
,
Taylor
P
. 2020 . Levothyroxine treatment and cholesterol in hypothyroidism . Nat Rev Endocrinol , 16 :193 –194 .
14.
Mohacsik
P
,
Erdelyi
F
,
Baranyi
M
,
Botz
B
,
Szabo
G
,
Toth
M
,
Haltrich
I
,
Helyes
Z
,
Sperlagh
B
,
Toth
Z
,
Sinko
R
,
Lechan
RM
,
Bianco
AC
,
Fekete
C
,
Gereben
B
. 2018 . A transgenic mouse model for detection of tissue-specific thyroid hormone action . Endocrinology , 159 :1159 –1171 .
15.
Ito
M
,
Miyauchi
A
,
Hisakado
M
,
Yoshioka
W
,
Ide
A
,
Kudo
T
,
Nishihara
E
,
Kihara
M
,
Ito
Y
,
Kobayashi
K
,
Miya
A
,
Fukata
S
,
Nishikawa
M
,
Nakamura
H
,
Amino
N
. 2017 . Biochemical markers reflecting thyroid function in athyreotic patients on levothyroxine monotherapy . Thyroid , 27 :484 –490 .